SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
17-Mar-23 4:11 PM View: | Ohr Pharmaceutical, Inc. (NBSE) | 16-Mar-23 | Grant | 54,200 | -- | -- | 181% 30.0K to 84.2K | |
21-Mar-22 4:06 PM View: | Ohr Pharmaceutical, Inc. (NBSE) | 18-Mar-22 | Private Purchase | 10,000 | $1.81 | $18,100.00 | 50% 20.0K to 30.0K | |
18-Mar-22 4:11 PM View: | Ohr Pharmaceutical, Inc. (NBSE) | 17-Mar-22 | Purchase | 10,000 | $1.74 | $17,400.00 | 100% 10.0K to 20.0K | |
18-Mar-22 4:11 PM View: | Ohr Pharmaceutical, Inc. (NBSE) | 16-Mar-22 | Private Purchase | 10,000 | $1.62 | $16,200.00 | 100% 0 to 10.0K | |
23-Jan-20 5:42 PM View: | Amneal Pharmaceuticals, Inc. (AMRX) | 22-Jan-20 | Payment of Exercise | 7,311 | $5.13 | $37,505.40 | (36%) 20.1K to 12.79K | |
23-Jan-20 5:42 PM View: | Amneal Pharmaceuticals, Inc. (AMRX) | 22-Jan-20 | Option Exercise | 20,096 | -- | -- | 100% 0 to 20.1K |